|
Delayed
Nasdaq
01:13:24 13/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.0226 USD | +29.14% |
|
-60.40% | -99.68% |
| 11-10 | Karyopharm Therapeutics Inc.(OTCPK:KPTI.Q) dropped from NASDAQ Composite Index | CI |
| 11-06 | Karyopharm Therapeutics Inc.(NasdaqGS:KPTI) dropped from S&P TMI Index | CI |
| Market Cap | 397K 359K 331K 300K 566K 37.31M 583K 3.98M 1.58M 19.95M 1.49M 1.46M 63.5M | P/E 2026 * |
-
| P/E 2027 * | -0.01x |
|---|---|---|---|---|---|
| Enterprise Value | 397K 359K 331K 300K 566K 37.31M 583K 3.98M 1.58M 19.95M 1.49M 1.46M 63.5M | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
95.35% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| KPTI | Delayed | |
CBOE
| KPTI | Real-time | |
|
Tradegate
| 25K0 | Real-time | |
|
Deutsche Boerse AG
| 25K0 | Delayed | |
|
Börse Stuttgart
| 25K0 | Delayed |
Last Transcript: Karyopharm Therapeutics Inc.
| 1 day | +36.00% | ||
| 1 week | -60.40% | ||
| Current month | -96.40% | ||
| 1 month | -95.29% | ||
| 3 months | -98.83% | ||
| 6 months | -99.73% | ||
| Current year | -99.68% |
| 1 week | 0.01 |  | 0.06 |
| 1 month | 0.01 | | 0.99 |
| Current year | 0.01 | | 10.99 |
| 1 year | 0.01 | | 10.99 |
| 3 years | 0.01 | | 29.25 |
| 5 years | 0.01 | | 220.95 |
| 10 years | 0.01 | | 444.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 58 | 03/05/2021 |
Lori Macomber
DFI | Director of Finance/CFO | 55 | 03/01/2025 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Barry Greene
BRD | Director/Board Member | 63 | 01/01/2013 |
| Director/Board Member | 61 | 01/04/2013 | |
Garen Bohlin
BRD | Director/Board Member | 78 | 03/10/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/10/26 | Sell | Controller/Auditor | -4,788 | 0.0211% | ||
| 1/10/26 | Sell | Controller/Auditor | -378 | 0.0017% | ||
| 1/9/26 | Sell | Controller/Auditor | -19 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +29.14% | -60.40% | -99.57% | -99.79% | 397K | |
| +0.96% | +6.47% | +42.76% | +137.14% | 1,280B | |
| +2.00% | +4.84% | +46.87% | +93.40% | 675B | |
| +0.73% | +3.26% | +27.62% | +114.69% | 521B | |
| +1.14% | +3.78% | +39.98% | +70.26% | 386B | |
| +1.31% | +1.42% | +62.96% | +45.44% | 363B | |
| +1.11% | +0.07% | +28.19% | +58.61% | 301B | |
| +0.24% | -0.80% | +3.05% | +35.93% | 286B | |
| +0.84% | +2.51% | +40.31% | +76.92% | 253B | |
| +0.70% | +1.80% | +38.23% | +127.65% | 211B | |
| Average | +4.50% | -8.06% | +23.04% | +66.03% | 428B | |
| Weighted average by Cap. | +1.08% | +0.20% | +38.97% | +97.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 135M 122M 113M 102M 193M 12.71B 199M 1.35B 538M 6.8B 507M 497M 21.63B | 173M 156M 144M 131M 246M 16.24B 254M 1.73B 688M 8.68B 648M 634M 27.63B |
| Net income | -156M -141M -130M -118M -222M -14.67B -229M -1.56B -621M -7.84B -585M -573M -24.96B | -116M -105M -97.15M -87.93M -166M -10.94B -171M -1.17B -463M -5.85B -437M -427M -18.62B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | US$0.0226 | +29.14% | 2,018,680 |
| 11/11/26 | US$0.0175 | +0.57% | 8,281,735 |
| 10/11/26 | US$0.0174 | -56.50% | 146,821,550 |
| 09/11/26 | US$0.0400 | -27.14% | 23,722,490 |
| 06/11/26 | US$0.0549 | -8.65% | 104,537,597 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- KPTI Stock
Select your edition
All financial news and data tailored to specific country editions
